Discover

AARD
Aardvark Therapeutics, Inc.
5.04
2 x 3.81
2 x 6.06
bid
ask
-
0.18
3.45%
2 @ 04:00 PM
5.04 +0.00 (0.00%)
Ytd-61.61%
1y-70.44%
4.66
day range
5.45
3.35
52 week range
17.94
Open5.28Prev Close5.22Low4.66High5.45Mkt Cap110.30M
Vol251.85KAvg Vol209.48KEPS-3.10P/EN/AForward P/EN/A
Beta3.80Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg6.07200-d Avg7.331yr Est0.00

AARD News

AARDVARK THERAPEUTICS (AARD) SECURITIES CLASS ACTION: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline
newsfilecorp.com
AARDVARK THERAPEUTICS (AARD) SECURITIES CLASS ACTION: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages I

New York, New York--(Newsfile Corp. - October 6, 2026) - AARDVARK THERAPEUTICS SECURITIES CLASS ACTI

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD
globenewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Ce

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glan

LOS ANGELES, Oct. 06, 2026 (GLOBE NEWSWIRE) --  Glancy Prongay Wolke & Rotter LLP reminds investors

Aardvark Therapeutics (AARD) Investors: Securities Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
prnewswire.com
Aardvark Therapeutics (AARD) Investors: Securities Class Action Filed, Contact Hagens Berman Before

SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder

Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action F

New class action for Aardvark (AARD) urges investors to seek recovery for alleged securities fraud v

AARD Investor Alert: Aardvark Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt
globenewswire.com
AARD Investor Alert: Aardvark Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt

A securities class action alleges Aardvark Therapeutics promised investors a "99% gut-restricted" dr

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline
globenewswire.com
AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encou

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- AARDVARK THERAPEUTICS SECURITIES CLASS ACTION: Rosen Law

AARD 8-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline
newsfilecorp.com
AARD 8-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity

San Francisco, California--(Newsfile Corp. - October 5, 2026) - Hagens Berman Sobol Shapiro LLP, a n

Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
globenewswire.com
Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

AARD FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
newsfilecorp.com
AARD FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investo

New York, New York--(Newsfile Corp. - October 5, 2026) - WHY: Rosen Law Firm, a global investor righ

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glan

LOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o

AARD Deadline Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of Securities Class Action Deadline on October 13, 2026
globenewswire.com
AARD Deadline Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of Securi

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP encourages investors who suffered

If You Lost Money Investing in Aardvark Therapeutics, Inc. (AARD) Contact Robbins LLP for Information About Recovering Your Losses
newsfilecorp.com
If You Lost Money Investing in Aardvark Therapeutics, Inc. (AARD) Contact Robbins LLP for Informatio

San Diego, California--(Newsfile Corp. - October 5, 2026) - Shareholder rights law firm Robbins LLP

DEADLINE ALERT for UWMC, HDB, SMPL, and AARD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
DEADLINE ALERT for UWMC, HDB, SMPL, and AARD: The Law Offices of Frank R. Cruz Reminds Investors of

LOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors th

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
newsfilecorp.com
AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SB

LOS ANGELES, Oct. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold

AARDVARK DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
newsfilecorp.com
AARDVARK DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor righ

AARD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
newsfilecorp.com
AARD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securi

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

AARDVARK DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
newsfilecorp.com
AARDVARK DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors

New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor righ

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, remin

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD),

Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit
newsfilecorp.com
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardva

San Francisco, California--(Newsfile Corp. - October 2, 2026) - Hagens Berman Sobol Shapiro LLP, a n

AARDVARK DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD
globenewswire.com
AARDVARK DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors

NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action F

New class action for Aardvark (AARD) urges investors to seek recovery for alleged securities fraud v

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SB

LOS ANGELES, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shar

AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
prnewswire.com
AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Clas

A securities class action alleges Aardvark Therapeutics overstated the clinical, regulatory, and com

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
prnewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Ce

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been

AARD 12-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline
prnewswire.com
AARD 12-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity

SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder

AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Before the October 13, 2026 Lead Plaintiff Deadline
prnewswire.com
AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Be

SAN DIEGO, Sept. 30, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors

AARDVARK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline in Securities Class Action - AARD
newsfilecorp.com
AARDVARK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors

New York, New York--(Newsfile Corp. - September 30, 2026) - WHY: Rosen Law Firm, a global investor r

Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
globenewswire.com
Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
prnewswire.com
AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Shou

A securities class action alleges Aardvark Therapeutics' Chief Executive Officer, Chief Financial Of

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action, Encourages Investors with Losses to Contact the Firm
globenewswire.com
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Fili

SAN FRANCISCO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national shareh

AARD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
newsfilecorp.com
AARD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Deadline
globenewswire.com
AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aardvark Therape

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor

benzinga.com
RBC Capital Reiterates Sector Perform on Aardvark Therapeutics, Maintains $6 Price Target

RBC Capital analyst Brian Abrahams reiterates Aardvark Therapeutics (NASDAQ:AARD) with a Sector P

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Scholar Rock surged 11.9% after FDA approved ISEMBYLD for SMA; Scinai, Intercont and Rum led premark